15-min delayed · Aug 25, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 1 firms covering GeoVax Labs Inc, 0 rate it Buy or better, 1 sit at Hold, and 0 rate it Sell or worse, a hold consensus. Targets are tightly clustered, $1.00 to $1.00, so the covering firms are broadly aligned. The average target of $1.00 sits 56% above the current $0.64. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $-1.20 next quarter toward $-2.85 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS1 ratings
Hold
Strong Buy00%
Buy00%
Hold1100%
Sell00%
Strong Sell00%
Based on 1 analysts giving stock ratings to GeoVax Labs Inc.
As of Aug, 0 of 1 firms rate GOVX a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
GOVX EPS & revenue forecast
EPS · NEXT QUARTER
$-1.20
Range $-1.20 – $-1.20 · 1 analysts
Next period, 1 analysts expect GeoVax Labs Inc to earn $-1.20 a share (range $-1.20 – $-1.20), versus — a year earlier. Full-year consensus is $-5.14, growing to $-2.85 the year after.
REVENUE · NEXT QUARTER
$0
Range $0 – $0 · 1 analysts
Revenue is expected to reach $0 (range $0 – $0). Full-year consensus is $0, rising to $0 next year.
Top analysts covering GeoVax Labs Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on GOVX.
#1
Jason Kolbert
D. Boral Capital · Rank #407
Hold
$1.00+56.0% to target
Overall win rate
22%
+ Follow
#2
Vernon Bernardino
HC Wainwright & Co. · Rank #440
Buy
$8.00+1147.9% to target
Overall win rate
14%
+ Follow
#3
Jonathan Aschoff
Roth MKM · Rank #444
Buy
$10.00+1459.8% to target
Overall win rate
28%
+ Follow
#4
James Molloy
Alliance Global Partners · Rank #445
Buy
$212.50+33046.2% to target
Overall win rate
25%
+ Follow
#5
Jason Kolbert
EF Hutton
Buy
$18.00+2707.7% to target
Coverage
—
+ Follow
GOVX stock forecast FAQ
What is GOVX's average 12-month price target?+
The 1 analysts with a live target average $1.00 for GeoVax Labs Inc over the next 12 months, ranging from a $1.00 high to a $1.00 low.
Is GOVX stock a Buy, Sell or Hold right now?+
The current consensus is Hold. Of the 1 analyst ratings, 0 are Buy or Strong Buy, 1 are Hold, and 0 are Sell or Strong Sell.
How many Wall Street analysts cover GOVX?+
1 analysts have an active rating on GeoVax Labs Inc, and 1 firms carry a live 12-month price target.
Who is the most accurate analyst covering GOVX?+
Among analysts who currently cover GOVX, Jason Kolbert of D. Boral Capital has the strongest overall Quantellect track record (Rank #407). Their current call is Hold with a $1.00 target.
What is GeoVax Labs Inc's projected EPS for next quarter?+
The consensus estimate is $-1.20 per share (range $-1.20 – $-1.20) across 1 analysts. Full-year EPS is projected at $-5.14, rising to $-2.85 the following year.
How much revenue is GeoVax Labs Inc expected to report next quarter?+
Consensus revenue is $0 (range $0 – $0). Full-year revenue is projected at $0, growing to $0 next year.
Have analysts been upgrading or downgrading GOVX lately?+
As of Aug, 0 of 1 firms rate GOVX a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their GOVX calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
